Get started
Author

Jens Markus Chemnitz

Observed names: J Chemnitz, J M Chemnitz, J. Chemnitz, Jens Chemnitz, Jens M Chemnitz, Jens M. Chemnitz, Jens Marcus Chemnitz, Jens-Markus Chemnitz, Jens‐Markus Chemnitz
OpenAlex ID: A5000559744
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
2005 · Richard V. Parry, Jens M. Chemnitz, et al. · Molecular and Cellular Biology · 1,930
SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation
2004 · Jens M Chemnitz, Richard V Parry, et al. · The Journal of Immunology · 1,243
CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition
2006 · Michael S. von Bergwelt-Baildon, Alexey Popov, et al. · Blood · 240
PDF
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults
2014 · Udo Holtick, Melanie Albrecht, et al. · Cochrane Database of Systematic Reviews · 151
PDF
Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab
2002 · Jens Chemnitz, Andreas Draube, et al. · American Journal of Hematology · 127
PDF
Prostaglandin E2 Impairs CD4+ T Cell Activation by Inhibition of lck: Implications in Hodgkin's Lymphoma
2006 · Jens M. Chemnitz, Julia Driesen, et al. · Cancer Research · 100
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas
2021 · Nora Liebers, Johannes Duell, et al. · Blood Advances · 96
PDF
B and T Lymphocyte Attenuator-Mediated Signal Transduction Provides a Potent Inhibitory Signal to Primary Human CD4 T Cells That Can Be Initiated by Multiple Phosphotyrosine Motifs
2006 · Jens M Chemnitz, Anthony R Lanfranco, et al. · The Journal of Immunology · 85
Tumor-necrosis factor impairs CD4+ T cell–mediated immunological control in chronic viral infection
2016 · Marc Beyer, Zeinab Abdullah, et al. · Nature Immunology · 84
RNA fingerprints provide direct evidence for the inhibitory role of TGFβ and PD-1 on CD4+ T cells in Hodgkin lymphoma
2007 · Jens M. Chemnitz, Daniela Eggle, et al. · Blood · 80
Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults—a systematic review and meta-analysis
2014 · Udo Holtick, Melanie Albrecht, et al. · Critical Reviews in Oncology/Hematology · 71
OCTET ‐ CY : a phase II study to investigate the efficacy of post‐transplant cyclophosphamide as sole graft‐versus‐host prophylaxis after allogeneic peripheral blood stem cell transplantation
2015 · Udo Holtick, Jens‐Markus Chemnitz, et al. · European Journal Of Haematology · 69
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms.
2004 · Jens M. Chemnitz, James L. Riley, et al. · Blood · 68
Brentuximab Vedotin Combined With Donor Lymphocyte Infusions for Early Relapse of Hodgkin Lymphoma After Allogeneic Stem-Cell Transplantation Induces Tumor-Specific Immunity and Sustained Clinical Remission
2012 · Sebastian Theurich, Joke Malcher, et al. · Journal of Clinical Oncology · 67
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia
2021 · Christina Rautenberg, Friedrich Stölzel, et al. · Blood Cancer Journal · 64
PDF
Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults
2012 · Sebastian Theurich, Hans Fischmann, et al. · Cochrane Database of Systematic Reviews · 56
Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization
1999 · M Reiser, A Josting, et al. · Bone Marrow Transplantation · 48
Human Resting CD4+ T Cells Are Constitutively Inhibited by TGFβ under Steady-State Conditions
2007 · Sabine Classen, Thomas Zander, et al. · The Journal of Immunology · 40
PDF
Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis—A systematic review and meta-analysis
2013 · Sebastian Theurich, Hans Fischmann, et al. · Critical Reviews in Oncology/Hematology · 38
Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma
2019 · Joerg T. Hartmann, Hans-G. Kopp, et al. · European Journal of Cancer · 37
Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab
2010 · Jens Marcus Chemnitz, Jens Uener, et al. · Annals of Hematology · 36
Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia
2011 · Jens Marcus Chemnitz, Marie von Lilienfeld-Toal, et al. · Annals of Hematology · 30
FLAMSA reduced‐intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission
2015 · Udo Holtick, Alexander Shimabukuro‐Vornhagen, et al. · European Journal Of Haematology · 24
Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial
2011 · J. Janne Vehreschild, Gregor Moritz, et al. · International Journal of Antimicrobial Agents · 24
Similar outcome after allogeneic stem cell transplantation with a modified FLAMSA conditioning protocol substituting 4 Gy TBI with treosulfan in an elderly population with high-risk AML
2016 · Udo Holtick, Marco Herling, et al. · Annals of Hematology · 23
Works count: 70
Citation count: 5,028
H-index: 24
I10-index: 33
Year
Topic
Type